Biocodex, Inc. is the U.S. subsidiary of Biocodex, a family-owned international pharmaceuticals company founded in France in 1953. At Biocodex, we listen to the needs of patients, caregivers, and healthcare professionals to develop innovative products and solutions to help ease the burden of rare diseases. As the makers of DIACOMIT® we are dedicated to advancing scientific research and using our expertise to benefit the rare disease community.
Biocodex, Inc. is the U.S. subsidiary of Biocodex, a family-owned multi-international pharmaceuticals company founded in France in 1953, with proven expertise in treatment for the central nervous system. As the maker of DIACOMIT, we are dedicated to providing education and support to our healthcare providers, affected individuals, and their families.